+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market - Global Forecast 2025-2030- Product Image
Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market - Global Forecast 2025-2030- Product Image
Sale

Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6138945
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The paroxetine hydrochloride enteric-coated sustained-release tablet market is undergoing pivotal transformation as demand intensifies for advanced mental health therapeutics supporting improved patient adherence and therapeutic consistency. Senior stakeholders are seeking targeted insights on evolving delivery technologies, regulatory pressures, and supply chain strategies shaping this dynamic landscape.

Market Snapshot

The global paroxetine hydrochloride enteric-coated sustained-release tablet market is experiencing continued expansion, propelled by heightened awareness of mental health needs and the adoption of sophisticated drug formulations. As healthcare practitioners focus on optimizing outcomes for anxiety and depressive disorders, innovations in drug-delivery methods are creating new opportunities and reinforcing market attractiveness for forward-thinking life sciences organizations. Market drivers include clinical demand for improved adherence tools, regulatory refinements for modified-release systems, and the increasing need for scalable manufacturing networks capable of navigating global supply chain challenges.

Scope & Segmentation of the Paroxetine Hydrochloride Tablet Market

This report provides an in-depth analysis of the paroxetine hydrochloride enteric-coated sustained-release tablet landscape through comprehensive segmentation and regional breakdowns, enabling precise targeting and differentiation.

  • Indication: Covers major depressive disorder, generalized anxiety disorder, obsessive compulsive disorder, panic disorder, premenstrual dysphoric disorder, and social anxiety disorder.
  • Strength: Analyzes 12.5 mg, 25 mg, 37.5 mg, and 50 mg dosage strengths relevant for initiation, titration, and maintenance phases.
  • Patient Age Group: Considers therapy needs spanning adolescents, adults, and elderly populations.
  • Distribution Channel: Explores hospital pharmacy, online pharmacy, and retail pharmacy supply routes.
  • Sales Channel: Evaluates both online and offline commercial strategies.
  • Regions: Examines Americas (U.S., Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, South Africa, Saudi Arabia, and others), and Asia-Pacific (key markets such as China, India, Japan, and Australia).
  • Manufacturers: Profiles prominent companies such as GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, Viatris Inc, Dr. Reddy’s Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Cipla Ltd, Aurobindo Pharma Ltd, Apotex Inc, and Lupin Ltd.
  • Core Technologies: Assesses developments in enteric coating, sustained-release matrices, precision extrusion, novel polymers, and integration with digital patient engagement platforms.

Key Takeaways for Senior Decision-Makers

  • Enteric-coated sustained-release paroxetine hydrochloride tablets deliver steady plasma concentrations, supporting long-term adherence and minimizing the incidence of peak-related side effects.
  • Regulatory changes are advancing performance benchmarks, motivating manufacturers to refine in vitro–in vivo correlations and invest in next-generation release profiles.
  • Pharmaceutical companies are working closely with digital health providers and supply chain partners, embracing partnerships to optimize delivery and enhance patient engagement.
  • Diversified sourcing strategies and domestic manufacturing initiatives are mitigating raw material risk and production disruptions tied to new tariff regulations.
  • Segmentation by indication, age group, and strength guides product positioning, informing clinician and pharmacy-led marketing strategies tailored to unmet therapeutic needs.
  • Competitive differentiation is achieved through collaborative alliances, proprietary delivery innovation, and value-added features such as connected packaging and real-world outcomes integration.

Tariff Impact on Cost and Supply Chain

Revised U.S. tariff policies commencing in 2025 have prompted active pharmaceutical ingredient cost escalation and complexified import flows for paroxetine hydrochloride sustained-release tablets. Manufacturers are expanding domestic partnerships and adjusting procurement strategies to stabilize production lead times, while contract manufacturing organizations are reevaluating shift scheduling and component prioritization to manage supply volatility. Cross-functional supply chain, quality, and regulatory teams are now integrating tariff analysis from the outset of formulation development to preserve margin integrity and ensure reliable market access.

Methodology & Data Sources

The report leverages a blended research approach, incorporating structured interviews with subject-matter experts, supply chain managers, and regulatory professionals, complemented by comprehensive analysis of published scientific literature, regulatory documents, and patent databases. Analytical frameworks, including SWOT assessments and scenario modeling for tariff impact, validate insights and provide actionable intelligence across the product lifecycle.

Why This Report Matters

  • Enables strategic portfolio allocation by clarifying the highest-potential segments, regional opportunities, and technology trends in the paroxetine hydrochloride tablet market.
  • Supports proactive risk mitigation with scenario planning for regulatory, supply chain, and tariff-driven disruptions.
  • Empowers decision-makers to target investment, innovation, and partnership strategies based on robust, triangulated market intelligence.

Conclusion

A comprehensive understanding of the paroxetine hydrochloride sustained-release tablet sector equips senior leaders with the insights to address evolving patient, regulatory, and market demands. Positioning for growth requires agile strategy, strong alliances, and continual focus on technology-enabled delivery and risk management.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising demand for personalized mental health treatments driving sustained-release paroxetine tablet innovation
5.2. Regulatory shifts in enteric-coated formulation approvals impacting global paroxetine hydrochloride market access
5.3. Integration of digital adherence technologies with sustained-release paroxetine tablets to improve patient compliance
5.4. Expansion of generic paroxetine hydrochloride enteric-coated sustained-release products increasing pricing pressure
5.5. Technological advances in gastro-resistant coatings enhancing stability and tolerability of paroxetine tablets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market, by Indication
8.1. Introduction
8.2. Generalized Anxiety Disorder
8.3. Major Depressive Disorder
8.4. Obsessive Compulsive Disorder
8.5. Panic Disorder
8.6. Premenstrual Dysphoric Disorder
8.7. Social Anxiety Disorder
9. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market, by Strength
9.1. Introduction
9.2. 12.5 Mg
9.3. 25 Mg
9.4. 37.5 Mg
9.5. 50 Mg
10. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market, by Patient Age Group
10.1. Introduction
10.2. Adolescents
10.3. Adults
10.4. Elderly
11. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market, by Sales Channel
12.1. Introduction
12.2. Offline
12.3. Online
13. Americas Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. GlaxoSmithKline plc
16.3.2. Teva Pharmaceutical Industries Ltd
16.3.3. Sandoz International GmbH
16.3.4. Viatris Inc
16.3.5. Dr. Reddy’s Laboratories Ltd
16.3.6. Sun Pharmaceutical Industries Ltd
16.3.7. Cipla Ltd
16.3.8. Aurobindo Pharma Ltd
16.3.9. Apotex Inc
16.3.10. Lupin Ltd
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET: RESEARCHAI
FIGURE 26. PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET: RESEARCHSTATISTICS
FIGURE 27. PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET: RESEARCHCONTACTS
FIGURE 28. PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY OBSESSIVE COMPULSIVE DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY OBSESSIVE COMPULSIVE DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PANIC DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PANIC DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PREMENSTRUAL DYSPHORIC DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PREMENSTRUAL DYSPHORIC DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SOCIAL ANXIETY DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SOCIAL ANXIETY DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY 12.5 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY 12.5 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY 25 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY 25 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY 37.5 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY 37.5 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY 50 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY 50 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY ADOLESCENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY ELDERLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 79. CANADA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 80. CANADA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 81. CANADA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 82. CANADA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 83. CANADA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 84. CANADA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 85. CANADA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. CANADA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. CANADA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. CANADA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. MEXICO PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 90. MEXICO PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 91. MEXICO PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 92. MEXICO PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 93. MEXICO PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 94. MEXICO PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 95. MEXICO PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. MEXICO PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. MEXICO PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. MEXICO PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 113. ARGENTINA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 114. ARGENTINA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 134. UNITED KINGDOM PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 136. UNITED KINGDOM PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. UNITED KINGDOM PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. UNITED KINGDOM PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. GERMANY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. GERMANY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. GERMANY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 144. GERMANY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 145. GERMANY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 146. GERMANY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 147. GERMANY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. GERMANY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. GERMANY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. GERMANY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. FRANCE PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 152. FRANCE PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 153. FRANCE PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 154. FRANCE PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 155. FRANCE PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 156. FRANCE PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 157. FRANCE PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. FRANCE PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. FRANCE PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. FRANCE PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 163. RUSSIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 164. RUSSIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 165. RUSSIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 166. RUSSIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 167. RUSSIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. RUSSIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. RUSSIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. RUSSIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. ITALY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. ITALY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. ITALY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 174. ITALY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 175. ITALY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 176. ITALY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 177. ITALY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. ITALY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. ITALY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. ITALY PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. SPAIN PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 182. SPAIN PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 183. SPAIN PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 184. SPAIN PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 185. SPAIN PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 186. SPAIN PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 187. SPAIN PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. SPAIN PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. SPAIN PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. SPAIN PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 204. SAUDI ARABIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 206. SAUDI ARABIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. SAUDI ARABIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. SAUDI ARABIA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 214. SOUTH AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 216. SOUTH AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. SOUTH AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. SOUTH AFRICA PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. DENMARK PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 222. DENMARK PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 223. DENMARK PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 224. DENMARK PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 225. DENMARK PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 226. DENMARK PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 227. DENMARK PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. DENMARK PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. DENMARK PAROXETINE HYDROCHLORIDE ENTERIC-COATED SUSTAINED-RELEASE TABLETS MARKET SIZE, BY SAL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets Market report include:
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd
  • Sandoz International GmbH
  • Viatris Inc
  • Dr. Reddy’s Laboratories Ltd
  • Sun Pharmaceutical Industries Ltd
  • Cipla Ltd
  • Aurobindo Pharma Ltd
  • Apotex Inc
  • Lupin Ltd

Related Topics

Related Reports

Paroxetine (CAS 61869-08-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Paroxetine (CAS 61869-08-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Anxiolytics Market - Global Forecast 2025-2030 - Product Image

Anxiolytics Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Anxiety Drugs Market - Global Forecast 2025-2030 - Product Image

Anxiety Drugs Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Psychotropic Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Psychotropic Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Major Depressive Disorder (MDD) Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Image

Major Depressive Disorder (MDD) Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • 101 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.